ORPHA:138044 Q87.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Diagnosis of Robin sequence (isolated or syndrome-associated), a combination of glossoptosis, micrognathia and upper airway obstruction ? all three criteria must be met - Age at inclusion maximum 12 month - Any gestational age and any sex - Parent or guardian, who provided consent
Exclusion criteria
Exclusion criteria: Participants whose parents/guardians are unable to understand the study protocol or are unable to give informed consent, for example due to a language barrier.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective of the registry is to collect data on characteristics, applied therapy, adverse events, medical follow-up and outcome of children with Robin sequence, with the intention to gain a better understanding of Robin sequence and its therapeutic options an outcomes. | — |
Secondary
| Measure | Time frame |
|---|---|
| The registry intents to • to collect more information about the disease. • to improve the quality of currently applied treatment options. • to determine the frequency of complications and adverse events. • to compare diagnostic and therapeutic procedures in affected patients across Europe. • to evaluate the effects of the different therapy options using several parameters such as MOA(H)I or z-scores at different time points. • to determine the long-term prognosis of the condition. • to generate a database for future research questions. • to enhance international cooperation. | — |
Countries
France, Germany, Netherlands, Switzerland, United Kingdom
Contacts
Center for Cleft Palate & Craniofacial Malformations; Tübingen University Hospital